II-VI, Inc. (IIVI) Tops Q2 EPS by 11c

II-VI, Inc. (NASDAQ: IIVI) reported Q2 EPS of $0.37, or $0.49 adjusted, $0.11 better than the analyst estimate of $0.26. Revenue for the quarter came in at $232 million versus the consensus estimate of $225.88 million.

Vincent D. Mattera, Jr., President and Chief Executive Officer, said “Our second fiscal quarter results reflect our strategy and the results of our efforts to address the growing market opportunities we are seeing, including those in the communications markets. Company margin expansion is being driven by volume and manufacturing efficiencies. With a book to bill ratio of 1.18, we anticipate the momentum we are currently experiencing to continue through the second half of fiscal year 2017.”

For earnings history and earnings-related data on II-VI, Inc. (IIVI) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c